Page 53 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

32 PART I The Biology and Pathogenesis of Cancer

260. Villamil JA, Henry CJ, Hahn AW, et al.: Hormonal and sex 284. Tokita H, Konishi S: Studies on canine oral papillomatosis. II.
impact on the epidemiology of canine lymphoma, J Cancer Epide- Oncogenicity of canine oral papilloma virus to various tissues of
miol590753, 2009. dog with special reference to eye tumor, Jpn J Vet Sci 37:109–120,
VetBooks.ir 261. Torres de la Riva G, Hart BL, Farver TB, et al.: Neutering dogs: 285. Bregman CL, Hirth RS, Sundberg JP, et al.: Cutaneous neoplasms
1975.
effects on joint disorders and cancers in golden retrievers, PLoS One
8:e55937, 2013.
262. Zink MC, Farhoody P, Elser SE, et al.: Evaluation of the risk and in dogs associated with canine oral papillomavirus, Vet Pathol
24:477–487, 1987.
age of onset of cancer and behavioral disorders in gonadectomized 286. Theilen GH, Madewell BR: Papillomatosis and fibromatosis. In
Vizslas, J Am Vet Med Assoc 244:309–319, 2014. Theilen GH, Madewell BR, editors: Veterinary cancer medicine,
263. Belanger JM, Bellumori TP, Bannasch DL, et al.: Correlation of Philadelphia, 1987, Lea &Febinger, pp 267–281.
neuter status and expression of heritable disorders, Canine Genet 287. Calvert CA: Canine viral papillomatosis. In Greene GE, editor:
Epidemiol 4(6), 2017. Infectious diseases of the dog and cat, Philadelphia, 1991, WB Saun-
264. Ru G, Terracini B, Glickman LT: Host related risk factors for ders, pp 288–290.
canine osteosarcoma, Vet J 156:31–39, 1998. 288. Callan MB, Preziosi D, Mauldin E: Multiple papillomavirus-asso-
265. Cooley DM, Beranek BC, Schlittler DL, et al.: Endogenous ciated epidermal hamartomas and squamous cell carcinomas in situ
gonadal hormone exposure and bone sarcoma risk, Cancer Epide- in a dog following treatment with prednisone and cyclosporine, Vet
miol Biomarkers Prev 11:1434–1440, 2002. Dermatol 16:338–345, 2005.
266. Kent MS, Burton JH, Dank G, et al.: Association of cancer-related 289. Nagata M: Canine papillomatosis. In Bonagura JD, editor: Kirk’s
mortality, age and gonadectomy in golden retriever dogs at a veteri- current veterinary therapy XIII, Philadelphia, 2000, WB Saunders,
nary academic center (1989-2016), PLoS One 13:e0192578, 2018. pp 569–571.
267. White CR, Hohenhaus AE, Kelsey J, et al.: Cutaneous MCTs: asso- 290. Bonney CH, Koch SA, Dice PF, et al.: Papillomatosis of con-
ciations with spay/neuter status, breed, body size, and phylogenetic junctiva and adnexa in dogs, J Am Vet Med Assoc 176:48–51,
cluster, J Am Anim Hosp Assoc 47:210–216, 2011. 1980.
268. Larsen AE, Grier RL: Evaluation of canine mast cell tumors for 291. Kuntsi-Vaattovaara H, Verstraete FJM, Newsome JT, et al.: Resolu-
presence of estrogen receptors, Am J Vet Res 50:1779–1780, 1989. tion of persistent oral papillomatosis in a dog after treatment with
269. Elling H, Ungemach FR: Sexual hormone receptors in canine mast a recombinant canine oral papillomavirus vaccine, Vet Comp Oncol
cell tumour cytosol, J Comp Pathol 92:629–630, 1982. 1:57–63, 2003.
270. Dow SW, Olson PN, Rosychuk RAW, et al.: Perianal adenomas 292. Bomholt A: Interferon therapy for laryngeal papillomatosis in
and hypertestosteronemia in a spayed bitch with pituitary-depen- adults, Arch Otolaryngol 109:550–552, 1983.
dent hyperadrenocorticism, J Am Vet Med Assoc 192:1439–1441, 293. Sundberg JP, Smith EK, Herron AJ, et al.: Cutaneous verrucosis in
1988. a Chinese Sharpei dog, Vet Pathol 31:183–187, 1994.
271. Wilson GP, Hayes Jr HM: Castration for treatment of perianal 294. Nagata M, Nanko H, Moriyana A, et al.: Pigmented plaques associ-
gland neoplasms in the dog, J Am Vet Med Assoc 174:1301–1303, ated with papillomavirus infection in dogs: is this epidermodyspla-
1979. sia verruciformis? Vet Dermatol 6:179–186, 1995.
272. Waters DJ, Sakr WA, Hayden DW, et al.: Workgroup 4: Spontane- 295. Bregman CL, Hinth RS, Sundberg JP, et al.: Cutaneous neoplasms
ous prostate carcinoma in dogs and nonhuman primates, Prostate in dogs associated with canine oral papillomavirus vaccine, Vet
36:64–67, 1998. Pathol 24:477–487, 1987.
273. Madewell BR, Gandour-Edwards R, DeVere White RW: Canine 296. Meunier LD: Squamous cell carcinoma in beagles subsequent to
prostatic intraepithelial neoplasia: is the comparative model rel- canine oral papillomavirus vaccine, Lab Anim Sci 40:568, 1990
evant? Prostate 58:314–317, 2004. (Abstract).
274. Teske E, Naan EC, Van Dijk EM, et al.: Canine prostate carci- 297. Munday JS, Willis KA, Kiupel M, et al.: Amplification of three dif-
noma: epidemiological evidence of an increased risk in castrated ferent papillomaviral DNA sequences from a cat with viral plaques,
dogs, Mol Cell Endocrinol 197:251–255, 2002. Vet Dermatol 19:400–404, 2008.
275. Sorenmo KU, Goldschmidt M, Shofer F, et al.: Immunohisto- 298. Schulman FY, Krafft AE, Janczewski T, et al.: Cutaneous fibropap-
chemical characterization of canine prostatic carcinoma and cor- illoma in a mountain lion (Felis concolor), J Zoo Wildl Med 34:179–
relation with castration status and castration time, Vet Comp Oncol 183, 2003.
1:48–56, 2003. 299. Sundberg JP, Van Ranst M, Montali R, et al.: Feline papillomas
276. Bryan JN, Keeler MR, Henry CJ, et al.: A population study of and papillomaviruses, Vet Pathol 37:1–10, 2000.
neutering status as a risk factor for canine prostate cancer, Prostate 300. Egberink HF, Horzinek MC: Feline viral papillomatosis. In Greene
67:1174–1181, 2007. CE, editor: Infectious diseases of the dog and cat, 2nd ed Philadel-
277. Benchimol S, Minden MD: Viruses, oncogenes, and tumor sup- phia, 1998, WB Saunders.
pressor genes. In Tannock IF, Hill RP, editors: The basic science of 301. Lozano-Alarcon F, Lewis TP, Clark EG, et al.: Persistent papil-
oncology, ed 3, New York, 1998, McGraw-Hill, pp 79–105. lomavirus infection in a cat, J Am Anim Hosp Assoc 32:392–396,
278. Pfister HH: Biology and biochemistry of papillomaviruses, Rev 1996.
Physiol Biochem Pharmacol 99:111–181, 1984. 302. LeClerc SM, Clark EG, Haines DM: Papillomavirus infection
279. Sundberg JP, Reszler AA, Williams ES, et al.: An oral papillomavi- in association with feline cutaneous squamous cell carcinoma
rus that infected one coyote and three dogs, Vet Pathol 28:87–88, in situ, Proc Am Assoc Vet Derm/Am Coll Vet Derm 13:125, 1997
1991. (abstract).
280. Munday JS, Knight CG: Amplification of feline sarcoid-associated 303. Schulman FY, Krafft AE, Janczewski T: Feline cutaneous fibropap-
papillomaviruses DNA sequences from bovine skin, Vet Dermatol illomas: clinicopathologic findings and association with papilloma-
21:341–344, 2010. virus infection, Vet Pathol 38:291–296, 2001.
281. Belkin PV: Ocular lesions in canine oral papillomatosis, Vet Med 304. Teifke JP, Kidney BA, Lohr CV, et al.: Detection of papillomavirus
Small Anim Clin 74:1520–1524, 1979. DNA in mesenchymal tumour cells and not in the hyperplastic
282. Watrach AM, Small E, Case MT: Canine papilloma: progression of epithelium of feline sarcoids, Vet Dermatol 14:47–56, 2003.
oral papilloma to carcinoma, J Natl Cancer Inst 45:915–920, 1970. 305. Gill VL, Bergman PJ, Baer KE, et al.: Use of imiquimod cream
283. Nicholls PE, Starley MA: The immunology of animal papillomavi- (Aldara) in cats with multicentric squamous cell carcinoma in situ:
ruses, Vet Immunol Immunopathol 73:101–127, 2000. 12 cases (2002-2005), Vet Comp Oncol 16:55–64, 2008.